Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.43 | N/A |
| PEG Ratio (TTM) | 3.88 | N/A |
| P/S Ratio (TTM) | 4.35 | N/A |
| P/B Ratio (TTM) | 1.30 | N/A |
| P/FCF Ratio (TTM) | -59.43 | N/A |
| Price to 5YR AVG Earnings Ratio | 18.29 | N/A |
| Price to 5YR AVG FCF Ratio | 11.24 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.08% | N/A |
| ROE (TTM) | 8.79% | N/A |
| Net Profit Margin (TTM) | 28.17% | N/A |
| ROIC 5YR AVG | 9.20% | N/A |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 4.26% | 52.74% | 30.87% |
| Revenue | 7.08% | 37.54% | 27.54% |
| Net Income | 4.24% | 87.72% | 53.42% |
| Cash Flow | -77.19% | 53.49% | 62.85% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.12 | N/A |
| Interest Coverage (TTM) | 0.65 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.44 | N/A |
| LTL to 5YR AVG FCF | 0.56 | N/A |
| Shares Outstanding Growth 5YR AVG | 17.90% | N/A |